Previous studies have demonstrated that aberrant modulation of EBF1, ETS1, ERG, and RUNX transcription factors has significant effects on lymphoid neoplasms derived from B cell progenitors [16, 17] (Fig. 4A). This evidence concerns the gene EBF1 and lymphoid neoplasm.